Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Cash from Investing Activities (2019 - 2025)

Biodesix's Cash from Investing Activities history spans 7 years, with the latest figure at -$104000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 88.24% year-over-year to -$104000.0; the TTM value through Dec 2025 reached -$403000.0, up 88.28%, while the annual FY2025 figure was -$403000.0, 88.28% up from the prior year.
  • Cash from Investing Activities reached -$104000.0 in Q4 2025 per BDSX's latest filing, down from -$67000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$67000.0 in Q3 2025 to a low of -$7.7 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$1.6 million, with a median of -$578500.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: crashed 2089.2% in 2023, then skyrocketed 96.46% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$641000.0 in 2021, then plummeted by 209.98% to -$2.0 million in 2022, then tumbled by 51.03% to -$3.0 million in 2023, then soared by 70.54% to -$884000.0 in 2024, then soared by 88.24% to -$104000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Cash from Investing Activities are -$104000.0 (Q4 2025), -$67000.0 (Q3 2025), and -$95000.0 (Q2 2025).